In our GBM samples analyzed, we did not find any differences in MR1 and CD45 levels between primary or recurrent tumors; however, in most cases, higher MR1 expression is correlated with higher CD45 staining implying MR1 expression might influence immune cell infiltration. Here, MR1 is linked to glioblastoma.